[Pharmacotherapy of venous disease].
D000925:Anticoagulants / Q000627:therapeutic use*; D003374:Coumarins / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005419:Flavonoids / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006496:Heparinoids / Q000627:therapeutic use; D024764:Hirudin Therapy; D006801:Humans; D007192:Indenes / Q000627:therapeutic use; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy*; D014648:Varicose Veins / Q000188:drug therapy*
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D005419:Flavonoids; D006496:Heparinoids; D007192:Indenes; D006493:Heparin; D013300:Streptokinase
Pharmakotherapie venöser Erkrankungen.